ClinicalTrials.Veeva

Menu

Tonic Versus Burst DR(TM) Epidural Motor Cortex Stimulation for Neuropathic Pain

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Neuropathic Pain

Treatments

Other: Retrospective analysis of patients' choice

Study type

Observational

Funder types

Other

Identifiers

NCT05984329
IRBN872022/CHUSTE

Details and patient eligibility

About

Epidural stimulation of the primary motor cortex (PMC) is indicated for the relief of neuropathic pain refractory to pharmacological treatment.

Full description

The main objective of this study is to compare the analgesic effect of two distinct waveforms (i.e. tonic versus Burst DR(TM)) delivered by an epidural stimulator of the (primary) motor cortex in patients suffering from neuropathic pain resistant to the best pharmacological treatment.

Enrollment

14 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients suffering from neuropathic pain refractory to best pharmacological treatment, operated on for MCS with an internal pulse generator (IPG) capable of delivering both tonic and Burst DR(TM) stimulation waveforms.

Exclusion criteria

  • Patients under 18 years old ; pregnancy

Trial design

14 participants in 2 patient groups

Tonic then Burst DR(TM)
Description:
Tonic Motor Cortex Stimulation (MCS) for 3 months then Burst DR(TM) MCS for 3 months
Treatment:
Other: Retrospective analysis of patients' choice
Burst DR(TM) then tonic
Description:
Burst DR(TM) MCS for 3 months then tonic MCS for 3 months
Treatment:
Other: Retrospective analysis of patients' choice

Trial contacts and locations

1

Loading...

Central trial contact

François VASSAL, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems